Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
March 31, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL
Q-Cells
cellular therapeutic comprised of human cells of the glial lineage
All Listed Sponsors
lead
Q Therapeutics, Inc.
INDUSTRY
NCT02478450 - Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter